New Results
No effect of administration of unacylated ghrelin on subcutaneous PC3 xenograft growth in a Rag1−/− mouse model of metabolic dysfunction
Michelle L. Maugham, View ORCID ProfileInge Seim, View ORCID ProfilePatrick B. Thomas, Gabrielle J. Crisp, Esha T. Shah, Adrian C. Herington, Kristy A. Brown, Laura S. Gregory, Colleen C. Nelson, Penny L. Jeffery, Lisa K. Chopin
doi: https://doi.org/10.1101/328351
Michelle L. Maugham
1Ghrelin Research Group, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
2Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
3Comparative and Endocrine Biology Laboratory, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
5Skeletal Biology and Forensic Anthropology Research Laboratory, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Inge Seim
1Ghrelin Research Group, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
2Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
3Comparative and Endocrine Biology Laboratory, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Patrick B. Thomas
1Ghrelin Research Group, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
2Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
3Comparative and Endocrine Biology Laboratory, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Gabrielle J. Crisp
1Ghrelin Research Group, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
2Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
3Comparative and Endocrine Biology Laboratory, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Esha T. Shah
1Ghrelin Research Group, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
2Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
3Comparative and Endocrine Biology Laboratory, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Adrian C. Herington
1Ghrelin Research Group, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
2Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Kristy A. Brown
4Department of Medicine, Weill Cornell Medicine, New York City, New York, United States of America.
Laura S. Gregory
5Skeletal Biology and Forensic Anthropology Research Laboratory, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Colleen C. Nelson
2Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Penny L. Jeffery
1Ghrelin Research Group, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
2Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
3Comparative and Endocrine Biology Laboratory, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Lisa K. Chopin
1Ghrelin Research Group, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
2Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
3Comparative and Endocrine Biology Laboratory, Translational Research Institute - Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Article usage
Posted May 22, 2018.
No effect of administration of unacylated ghrelin on subcutaneous PC3 xenograft growth in a Rag1−/− mouse model of metabolic dysfunction
Michelle L. Maugham, Inge Seim, Patrick B. Thomas, Gabrielle J. Crisp, Esha T. Shah, Adrian C. Herington, Kristy A. Brown, Laura S. Gregory, Colleen C. Nelson, Penny L. Jeffery, Lisa K. Chopin
bioRxiv 328351; doi: https://doi.org/10.1101/328351
No effect of administration of unacylated ghrelin on subcutaneous PC3 xenograft growth in a Rag1−/− mouse model of metabolic dysfunction
Michelle L. Maugham, Inge Seim, Patrick B. Thomas, Gabrielle J. Crisp, Esha T. Shah, Adrian C. Herington, Kristy A. Brown, Laura S. Gregory, Colleen C. Nelson, Penny L. Jeffery, Lisa K. Chopin
bioRxiv 328351; doi: https://doi.org/10.1101/328351
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)